Lincoln Pharmaceuticals Reports 38% Profit Surge to Rs 29 Cr in December Quarter

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Lincoln Pharma's Q3 Profit Jumps 38% to Rs 29 Cr, Revenue Up 13%

Representational image (Image: News18)

N

News18•12-02-2026, 16:45

Lincoln Pharma's Q3 Profit Jumps 38% to Rs 29 Cr, Revenue Up 13%

•Lincoln Pharmaceuticals reported a 38% rise in consolidated net profit to Rs 29 crore in Q3 FY26.
•Revenue from operations increased by 13% to Rs 166 crore for the quarter ended December 2025.
•Director Munjal Patel aims for 15-18% annual growth, driven by cardiac, diabetic, dermatology, and ENT segments.
•The company is strengthening its R&D pipeline with over 100 new development programs and patent initiatives.
•Lincoln Pharma targets an annual revenue of Rs 1,000 crore within three years through expansion and new markets.

Read Full Article on News18 in English

✦

More like this

✦

More like this

Representational image (Image: News18)

Akums Drugs Q3 Net Profit Jumps 29.5% to Rs 86 Cr, Revenue Hits Rs 1,160 Cr

Representational image (Image: News18)

Grasim Q3 Profit Jumps 28.7% to Rs 2,233 Cr, Revenue Up 25%

Representational image (Image: News18)

Axiscades Q3 Net Profit Soars 87% to Rs 28 Cr on Strong Revenue Growth

Representational image (Image: News18)

GlaxoSmithKline Pharma Q3 Profit Jumps 29% to Rs 296 Cr

Representational image (Image: News18)

Diamond Power Infrastructure Profit Jumps to Rs 49 Cr in Oct-Dec Quarter

Representational image (Image: News18)

Abbott's Q3 Net Profit Rises 4% to Rs 376 Crore, Revenue Up